Gene Therapy Drug Pipeline Analysis

Publish Date:- Sep-2013      No Of Pages (185)

Electronic Access - Single User License $1500 Buy Now
CD-ROM Mail Delivery $1800Buy Now
Hard Copy Mail Delivery $2000 Buy Now
Electronic Access - Multi-User License $3000 Buy Now


Gene Therapy Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drugs being developed for the treatment of multiple disease based upon Gene Therapy. Research report covers all the ongoing drug development in various development phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Country of Development and detailed analysis on the development process. Insight for each drug profile in development phase enables the reader to identify and understand the Gene Therapy associated with the various diseases.

This report enables pharmaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the Gene Therapy based drug development process. Following parameters for each drug profile in development phase are covered in “Gene Therapy Drug Pipeline Analysis” research report:

• Drug Profile Overview

• Alternate Names for Drug

• Active Indication • Phase of Development

• Mechanism of Action

• Country for Clinical Trial

• Owner / Originator/ Licensee/Collaborator

• Administrative Route

• Drug Class

• ATC Codes



Number of Drug Profiles in Development Phases:

• Research: 4

• Preclinical: 49

• Phase I: 22

• Phase I/II: 14

• Phase II: 22

• Phase III: 2

• Preregistration: 1

• Registered: 1

• Marketed: 1


Gene Therapy Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drugs being developed for the treatment of multiple disease based upon Gene Therapy. Research report covers all the ongoing drug development in various development phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Country of Development and detailed analysis on the development process. Insight for each drug profile in development phase enables the reader to identify and understand the Gene Therapy associated with the various diseases.

This report enables pharmaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the Gene Therapy based drug development process. Following parameters for each drug profile in development phase are covered in “Gene Therapy Drug Pipeline Analysis” research report:

• Drug Profile Overview

• Alternate Names for Drug

• Active Indication • Phase of Development

• Mechanism of Action

• Country for Clinical Trial

• Owner / Originator/ Licensee/Collaborator

• Administrative Route

• Drug Class

• ATC Codes



Number of Drug Profiles in Development Phases:

• Research: 4

• Preclinical: 49

• Phase I: 22

• Phase I/II: 14

• Phase II: 22

• Phase III: 2

• Preregistration: 1

• Registered: 1

• Marketed: 1

1. Global Gene Therapy Market Overview

  1.1 What is Gene Therapy?

  1.2 Market Overview

  1.3 Favorable Market Dynamics

  1.4 Regulatory Framework: US & EU

  1.5 Emerging Trends in Gene Therapy



2. Gene Therapy Drug Development Phase: Research

  2.1 Overview

  2.2 Drug Profiles in Development Phase



3. Gene Therapy Drug Development Phase: Preclinical

  3.1 Overview

  3.2 Drug Profiles in Development Phase



4. Gene Therapy Drug Development Phase: Phase-I

  4.1 Overview

  4.2 Drug Profiles in Development Phase



5. Gene Therapy Drug Development Phase: Phase-I/II

  5.1 Overview

  5.2 Drug Profiles in Development Phase



6. Gene Therapy Drug Development Phase: Phase-II

  6.1 Overview

  6.2 Drug Profiles in Development Phase



7. Gene Therapy Drug Development Phase: Phase-III

  7.1 Overview

  7.2 Drug Profiles in Development Phase



8. Gene Therapy Drug Development Phase: Preregistration

  8.1 Overview

  8.2 Drug Profiles in Development Phase



9. Gene Therapy Drug Development Phase: Registered

  9.1 Overview

  9.2 Drug Profiles in Development Phase



10. Gene Therapy Drug Development Phase: Marketed

  10.1 Overview

  10.2 Drug Profiles in Development Phase


Each Drug Profile has Tables Representing Following Information:

• Alternate Names

• Originator & Owner

• Collaborator

• Technology Provider

• Licensee

• Highest Development Phase

• Indications

• Class

• Mechanism of Action

• ATC code

• Designated Brand Name & Orphan Designation